Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
BMC Cancer|November 26, 2009
The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control studyAdela Castillejo, Trinidad Mata-Balaguer, Carla Guarinos, et al.
The Journal of Molecular Diagnostics : JMD|May 22, 2010
Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndromeLucía Pérez-Carbonell, Cristina Alenda, Artemio Payá, et al.
Plos One|March 30, 2017
Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factorsMaria Andres-Franch, Antonio Galiana, Victoria Sanchez-Hellin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Utility of p16 immunohistochemistry for the identification of Lynch syndromeArtemio Payá, Cristina Alenda, Lucía Pérez-Carbonell, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2010
EPCAM germ line deletions as causes of Lynch syndrome in Spanish patientsCarla Guarinos, Adela Castillejo, Víctor-Manuel Barberá, et al.
The Journal of Gene Medicine|March 18, 2017
Characterization of a novel POLD1 missense founder mutation in a Spanish populationRosario Ferrer-Avargues, Virginia Díez-Obrero, Ester Martín-Tomás, et al.
Plos One|February 1, 2012
TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancerAna Martinez-Canto, Adela Castillejo, Trinidad Mata-Balaguer, et al.
International Journal of Cancer|November 13, 2008
TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosisAdela Castillejo, Nathaniel Rothman, Cristiane Murta-Nascimento, et al.
Plos One|September 7, 2018
Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapyOscar Murcia, Míriam Juárez, María Rodríguez-Soler, et al.
Hereditary Cancer in Clinical Practice|January 25, 2019
Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)Marta Ramírez-Calvo, Zaida García-Casado, Antonio Fernández-Serra, et al.
Pageof 4